Terms: = Gastric cancer AND MNX1, HB9, 3110, ENSG00000130675, P50219, HLXB9 AND Treatment
5 results:
1. Investigation on the cellular mechanism of Prunetin evidenced through next generation sequencing and bioinformatic approaches against gastric cancer.
Vetrivel P; Nachimuthu S; Abuyaseer A; Bhosale PB; Ha SE; Kim HH; Park MY; Kim GS
Sci Rep; 2022 Jul; 12(1):11852. PubMed ID: 35831348
[TBL] [Abstract] [Full Text] [Related]
2. TEAD4 modulated LncRNA mnx1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic and treatment strategy for small gastrointestinal stromal tumors.
Nishida T; Goto O; Raut CP; Yahagi N
Cancer; 2016 Oct; 122(20):3110-3118. PubMed ID: 27478963
[TBL] [Abstract] [Full Text] [Related]
4. PET-CT offers accurate assessment of tumour length in oesophageal malignancy.
Rollins KE; Lucas E; Tewari N; James E; Hughes S; Catton JA
Eur J Radiol; 2015 Feb; 84(2):195-200. PubMed ID: 25435270
[TBL] [Abstract] [Full Text] [Related]
5. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors.
Qin Y; Halmos G; Cai RZ; Szoke B; Ertl T; Schally AV
J Cancer Res Clin Oncol; 1994; 120(9):519-28. PubMed ID: 8045917
[TBL] [Abstract] [Full Text] [Related]
